Subscribe


PD breaking news – Medicines Regulation inquiry calls for comp meds submissions

Questions about efficacy testing, non-compliance deterrents posed. 

The panel conducting the Review of Medicines and Medical Devices Regulation has called for submissions from stakeholders regarding regulation of complementary medicines.

The panel, headed by Emeritus Professor Lloyd Sansom and announced last year (PD 27 Oct 14), released an addendum to its discussion paper today dealing with complementary medicines.

The chapter, which was flagged at the time of the Review’s announcement, asks various questions of stakeholders, including whether an ingredient should only be considered to have been ‘approved’ by an overseas regulator if it had been subjected to assessment, and if so, whether this assessment should include quality, safety and efficacy.

The document said while Canadian regulators undertook pre-market evaluation of ingredients in complementary medicines for quality, safety and efficacy, the US Food and Drug Administration only require notification of a new ingredient and demonstration of a reasonable expectation of safety for use in a dietary supplement.

“As such, ‘approval’ of a new ingredient in Canada means something quite different than ‘approval’ of a new ingredient in the US.

“In Australia, the TGA assesses quality and safety of a new ingredient, but does not undertake an assessment of efficacy.”

Other questions asked of stakeholders include whether Australia should adopt approval of ingredients by ‘trusted’ overseas regulators, whether the current regulatory regime for complementary medicines in Australia is commensurate with the risk posed by products, and whether low-risk complementary medicines should be regulated as general consumer goods, rather than having to be listed on the Australian Register of Therapeutic Goods.

The chapter also asks whether current legislation provided sufficient deterrents to prevent sponsors “knowingly listing non-compliant complementary medicines” on the Register, citing the fact that sponsors could request a product be removed from the Register if it is subjected to a review by the Therapeutic Goods Administration, and re-list it at a later date.

Submissions on the addendum are due by 08 Apr.

For more, see Monday’s Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 20 Feb 15

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

26 Feb

Weekly Comment 26 Feb 18 - WELCOME to PD's weekly comment feature. This ...


26 Feb

Dispensary Corner 26 Feb 18 - REPRODUCTION experts have long held the view ...


26 Feb

Low BC awareness - A NEW report published in Public Health ...


26 Feb

Champix cardiac link - NEW research published in the American Journal ...


26 Feb

Pharmacy’s future - ALL APP Conference 2018 attendees are being ...


26 Feb

Pharmacy chronic pain - DESPITE protestations by pharmacists that they have ...


26 Feb

APC consultant call - THE Australian Pharmacy Council (APC) is calling ...


26 Feb

FDA beats EMA - FROM 2007 to 2016, the US Food ...


26 Feb

Cannabis claims challenge - CLAIMS that medical cannabis use has reduced ...


26 Feb

Beauty Prescription bash - PRICELINE Pharmacy transformed Sydney's Randwick Racecourse into ...


23 Feb

Dispensary Corner 23 Feb 18 - DEDICATION to the task, what every company ...


23 Feb

J&J choice employer - THE Johnson & Johnson Family of Companies ...


23 Feb

Abstract submissions - CHOOSING Wisely Australia, an NPS MedicineWise initiative ...


23 Feb

Codeine price hike - SINCE products containing codeine became prescription only ...


23 Feb

My Chemist wins Roy Morgan PoTY - AUSTRALIAN pharmacy retailer My Chemist has taken ...


23 Feb

E-cigs support detox - ELECTRONIC cigarettes, used as an alternative form ...


23 Feb

New $35m global Ego HQ - FEDERAL Minister for Health Greg Hunt officially ...


23 Feb

Blackmores profit up 20% - BLACKMORES has reported overall group revenue was ...


23 Feb

MCC on cautionary RACP - AUSTRALIA'S peak medical cannabis industry group, the ...


22 Feb

PD breaking news – Blackmores H1 profit up 20% - Blackmores H1 profit up 20%Blackmores has reported ...



Show Pharmacy Daily items by month: